Literature DB >> 19095421

The EQ-5D: A useful quality of life measure in borderline personality disorder?

A D I van Asselt1, C D Dirksen, A Arntz, J H Giesen-Bloo, J L Severens.   

Abstract

INTRODUCTION: Borderline Personality Disorder (BPD) is a severe psychiatric disorder and is associated with significant impairment in quality of life. The aim of the present study is to assess the internal and external responsiveness of the EuroQoL-5D (EQ-5D) in BPD patients. PATIENTS AND METHODS: Data from 49 patients included in a multi-center Dutch randomized trial were used. We used both the EQ-5D utility score and the Visual Analogue Scale of the EuroQoL, and the Borderline Personality Disorder Severity Index-IV (BPDSI-IV). To determine internal responsiveness, we calculated the standardized response mean (SRM). To determine external responsiveness, we calculated Spearman correlations for the change scores, and compared EQ-5D scores for clinically improved vs. non-clinically improved patients as measured with the BPDSI-IV.
RESULTS: Patient scores improved on all instruments during the three years. SRMs for BPDSI-IV were significantly higher than EQ-5D utility. Three-year Spearman correlation between change scores of BPDSI-IV and EQ-5D utility was 0.487, between BPDSI-IV and EQ-VAS it was 0.404, both statistically significant. EQ-5D utility scores for patients who clinically improved were significantly higher than for patients who did not. DISCUSSION: We conclude that the EQ-5D is fairly responsive in BPD, and, therefore, especially because of its brevity and user-friendliness, can serve as a useful tool in economic evaluations in patients with BPD.

Entities:  

Mesh:

Year:  2008        PMID: 19095421     DOI: 10.1016/j.eurpsy.2008.11.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  13 in total

1.  Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.

Authors:  Mike J Crawford; Rahil Sanatinia; Barbara Barrett; Sarah Byford; Gillian Cunningham; Kavi Gakhal; Geof Lawrence-Smith; Verity Leeson; Fenella Lemonsky; Georgia Lykomitrou; Alan Montgomery; Richard Morriss; Carol Paton; Wei Tan; Peter Tyrer; Joseph G Reilly
Journal:  Trials       Date:  2015-07-18       Impact factor: 2.279

2.  Day hospital Mentalization-based treatment versus intensive outpatient Mentalization-based treatment for patients with severe borderline personality disorder: protocol of a multicentre randomized clinical trial.

Authors:  Elisabeth M P Laurenssen; Maaike L Smits; Dawn L Bales; Dine J Feenstra; Hester V Eeren; Marc J Noom; Maartje A Köster; Zwaan Lucas; Reinier Timman; Jack J M Dekker; Patrick Luyten; Jan J V Busschbach; Roel Verheul
Journal:  BMC Psychiatry       Date:  2014-11-18       Impact factor: 3.630

3.  Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care.

Authors:  Nick Verhaeghe; Delphine De Smedt; Jan De Maeseneer; Lea Maes; Cornelis Van Heeringen; Lieven Annemans
Journal:  BMC Public Health       Date:  2014-08-18       Impact factor: 3.295

4.  The burden of disease in patients eligible for mentalization-based treatment (MBT): quality of life and costs.

Authors:  Elisabeth M P Laurenssen; Hester V Eeren; Martijn J Kikkert; Jaap Peen; Dieuwertje Westra; Jack J M Dekker; Jan J V Busschbach
Journal:  Health Qual Life Outcomes       Date:  2016-10-12       Impact factor: 3.186

5.  The effect of exercise as adjunctive treatment on quality of life for individuals with alcohol use disorders: a randomized controlled trial.

Authors:  Sengül Sari; Randi Bilberg; Anette Søgaard Nielsen; Kirsten Kaya Roessler
Journal:  BMC Public Health       Date:  2019-06-11       Impact factor: 3.295

Review 6.  Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review.

Authors:  Katharina Sophie Vogt; Paul Norman
Journal:  Psychol Psychother       Date:  2018-08-11       Impact factor: 3.915

7.  Day Hospital Mentalization-Based Treatment (MBT-DH) versus treatment as usual in the treatment of severe borderline personality disorder: protocol of a randomized controlled trial.

Authors:  Elisabeth M P Laurenssen; Dieuwertje Westra; Martijn J Kikkert; Marc J Noom; Hester V Eeren; Anna J van Broekhuyzen; Jaap Peen; Patrick Luyten; Jan J V Busschbach; Jack J M Dekker
Journal:  BMC Psychiatry       Date:  2014-05-22       Impact factor: 3.630

8.  Health related quality of life for young people receiving dialectical behaviour therapy (DBT): a routine outcome-monitoring pilot.

Authors:  M Swales; R A B Hibbs; L Bryning; R P Hastings
Journal:  Springerplus       Date:  2016-07-20

9.  Psychological Support for Personality (PSP) versus treatment as usual: study protocol for a feasibility randomized controlled trial of a low intensity intervention for people with personality disorder.

Authors:  Mike J Crawford; Lavanya Thana; Jennie Parker; Oliver Turner; Kwek Pei Xing; Mary McMurran; Paul Moran; Timothy Weaver; Barbara Barrett; Amy Claringbold; Paul Bassett; Rahil Sanatinia
Journal:  Trials       Date:  2018-10-10       Impact factor: 2.279

10.  Group schema-focused therapy enriched with psychomotor therapy versus treatment as usual for older adults with cluster B and/or C personality disorders: a randomized trial.

Authors:  S D M van Dijk; M S Veenstra; R Bouman; J Peekel; D H Veenstra; P J van Dalen; A D I van Asselt; M L Boshuisen; S P J van Alphen; R H S van den Brink; R C Oude Voshaar
Journal:  BMC Psychiatry       Date:  2019-01-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.